Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;7(10):e2439945.
doi: 10.1001/jamanetworkopen.2024.39945.

Recombinant Zoster Vaccination Among US Veterans Receiving Immunosuppressive Medications

Sharon Abada  1   2 , Jing Li  1   2 , Gary Tarasovsky  1   2 , Cherish Wilson  1   2 , Jinoos Yazdany  1 , Mary A Whooley  1   2   3 , Gabriela Schmajuk  1   2   3
Affiliations

Recombinant Zoster Vaccination Among US Veterans Receiving Immunosuppressive Medications

Sharon Abada et al. JAMA Netw Open. .
No abstract available

Plain language summary

This cross-sectional study investigates rates of recombinant zoster vaccination among US veterans receiving immunosuppressive medications before and after expanded indications for younger adults who are immunocompromised.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Schmajuk reported receiving grants from the National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases and Agency for Healthcare Research and a contract from the American College of Rheumatology paid to the University of California San Francisco during the conduct of the study. Dr Yazdany reported receiving grant support from Aurinia, Gilead, and the BMS Foundation and performing consulting for Aurinia, AstraZeneca, UCB, and Pfizer. Dr Whooley reported receiving grants from the National Institutes of Health National Center for Advancing Translational Sciences, National Institute of General Medical Sciences, and Agency for Healthcare Research and Quality. No other disclosures were reported.

References

    1. McKay SL, Guo A, Pergam SA, Dooling K. Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clin Infect Dis. 2020;71(7):e125-e134. doi: 10.1093/cid/ciz1090 - DOI - PMC - PubMed
    1. Marra F, Lo E, Kalashnikov V, Richardson K. Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis. Open Forum Infect Dis. 2016;3(4):ofw205. doi: 10.1093/ofid/ofw205 - DOI - PMC - PubMed
    1. Fink DL. Our STN: BL 125614/398 supplement approval. Accessed September 5, 2024. https://www.fda.gov/media/151063/download
    1. Anderson TC, Masters NB, Guo A, et al. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(3):80-84. doi: 10.15585/mmwr.mm7103a2 - DOI - PMC - PubMed
    1. Bass AR, Chakravarty E, Akl EA, et al. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2023;75(3):333-348. doi: 10.1002/art.42386 - DOI - PMC - PubMed

Publication types